V B Boesen, T H Hansen, M Motawea, M Fleseriu, E V Varlamov, A J Han, S A Imran, V Munro, M Alenazi, W J Inder, N Lenders, R A Damilano, N L Monteserin, A G Lania, G Carosi, G Mantovani, D Hordejuk, L Min, U B Kaiser, S D Rikvold, J Krogh
{"title":"无功能垂体微腺瘤的自然史:系统回顾和个体参与者数据荟萃分析。","authors":"V B Boesen, T H Hansen, M Motawea, M Fleseriu, E V Varlamov, A J Han, S A Imran, V Munro, M Alenazi, W J Inder, N Lenders, R A Damilano, N L Monteserin, A G Lania, G Carosi, G Mantovani, D Hordejuk, L Min, U B Kaiser, S D Rikvold, J Krogh","doi":"10.1093/ejendo/lvaf189","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Increased frequency of neuroimaging has led to enhanced identification of small non-functioning pituitary adenomas (NFPAs) leading, in many cases, to extensive follow-up. However, the value of ongoing monitoring of these incidental lesions remains unclear.The study aims to determine the need for surgical intervention and assess the risks of developing new endocrinopathies during follow-up in patients with conservatively treated micro-NFPAs.</p><p><strong>Design: </strong>A systematic review and individual participant data meta-analysis.</p><p><strong>Methods: </strong>We conducted a bibliographical search of PubMed and EMBASE to identify relevant studies. Authors of eligible studies were invited to share individual participant data.Cohort studies including patients with conservatively treated micro-NFPAs with at least one follow-up MRI were considered eligible.Fourteen studies met inclusion criteria. Six authors provided individual participant data (N=647). Data were re-analyzed for verification. In cases of discrepancies the original authors were contacted for authentication.</p><p><strong>Results: </strong>Risk estimates were reported as number of events per 100 person-years (PYs). Estimates were pooled using the two-step approach. Overall probability of surgery was 0.2/100PYs (95%CI: 0.0 to 0.4; I2=28%). Probability of surgery due to visual impairment was 0.1/100PYs (95%CI: 0.0 to 0.2; I2=0%). Both were independent of baseline tumor size (≥6 mm or <6 mm), sex, or age (p-values>0.40). Risk of developing a new endocrinopathy was 1.0/100PYs (95%CI: 0.4 to 1.6; I2=0%).Data for classical meta-analysis were available for 7 studies (N=1089) and supported the individual participant data results.</p><p><strong>Conclusions: </strong>These data suggest that routine follow-up of micro-NFPAs can be reduced significantly and that available guidelines should be revisited.</p>","PeriodicalId":11884,"journal":{"name":"European Journal of Endocrinology","volume":" ","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Natural history of non-functioning pituitary microadenomas: a systematic review and individual participant data meta-analysis.\",\"authors\":\"V B Boesen, T H Hansen, M Motawea, M Fleseriu, E V Varlamov, A J Han, S A Imran, V Munro, M Alenazi, W J Inder, N Lenders, R A Damilano, N L Monteserin, A G Lania, G Carosi, G Mantovani, D Hordejuk, L Min, U B Kaiser, S D Rikvold, J Krogh\",\"doi\":\"10.1093/ejendo/lvaf189\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Increased frequency of neuroimaging has led to enhanced identification of small non-functioning pituitary adenomas (NFPAs) leading, in many cases, to extensive follow-up. However, the value of ongoing monitoring of these incidental lesions remains unclear.The study aims to determine the need for surgical intervention and assess the risks of developing new endocrinopathies during follow-up in patients with conservatively treated micro-NFPAs.</p><p><strong>Design: </strong>A systematic review and individual participant data meta-analysis.</p><p><strong>Methods: </strong>We conducted a bibliographical search of PubMed and EMBASE to identify relevant studies. Authors of eligible studies were invited to share individual participant data.Cohort studies including patients with conservatively treated micro-NFPAs with at least one follow-up MRI were considered eligible.Fourteen studies met inclusion criteria. Six authors provided individual participant data (N=647). Data were re-analyzed for verification. In cases of discrepancies the original authors were contacted for authentication.</p><p><strong>Results: </strong>Risk estimates were reported as number of events per 100 person-years (PYs). Estimates were pooled using the two-step approach. Overall probability of surgery was 0.2/100PYs (95%CI: 0.0 to 0.4; I2=28%). Probability of surgery due to visual impairment was 0.1/100PYs (95%CI: 0.0 to 0.2; I2=0%). Both were independent of baseline tumor size (≥6 mm or <6 mm), sex, or age (p-values>0.40). Risk of developing a new endocrinopathy was 1.0/100PYs (95%CI: 0.4 to 1.6; I2=0%).Data for classical meta-analysis were available for 7 studies (N=1089) and supported the individual participant data results.</p><p><strong>Conclusions: </strong>These data suggest that routine follow-up of micro-NFPAs can be reduced significantly and that available guidelines should be revisited.</p>\",\"PeriodicalId\":11884,\"journal\":{\"name\":\"European Journal of Endocrinology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2025-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Endocrinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ejendo/lvaf189\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejendo/lvaf189","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Natural history of non-functioning pituitary microadenomas: a systematic review and individual participant data meta-analysis.
Objective: Increased frequency of neuroimaging has led to enhanced identification of small non-functioning pituitary adenomas (NFPAs) leading, in many cases, to extensive follow-up. However, the value of ongoing monitoring of these incidental lesions remains unclear.The study aims to determine the need for surgical intervention and assess the risks of developing new endocrinopathies during follow-up in patients with conservatively treated micro-NFPAs.
Design: A systematic review and individual participant data meta-analysis.
Methods: We conducted a bibliographical search of PubMed and EMBASE to identify relevant studies. Authors of eligible studies were invited to share individual participant data.Cohort studies including patients with conservatively treated micro-NFPAs with at least one follow-up MRI were considered eligible.Fourteen studies met inclusion criteria. Six authors provided individual participant data (N=647). Data were re-analyzed for verification. In cases of discrepancies the original authors were contacted for authentication.
Results: Risk estimates were reported as number of events per 100 person-years (PYs). Estimates were pooled using the two-step approach. Overall probability of surgery was 0.2/100PYs (95%CI: 0.0 to 0.4; I2=28%). Probability of surgery due to visual impairment was 0.1/100PYs (95%CI: 0.0 to 0.2; I2=0%). Both were independent of baseline tumor size (≥6 mm or <6 mm), sex, or age (p-values>0.40). Risk of developing a new endocrinopathy was 1.0/100PYs (95%CI: 0.4 to 1.6; I2=0%).Data for classical meta-analysis were available for 7 studies (N=1089) and supported the individual participant data results.
Conclusions: These data suggest that routine follow-up of micro-NFPAs can be reduced significantly and that available guidelines should be revisited.
期刊介绍:
European Journal of Endocrinology is the official journal of the European Society of Endocrinology. Its predecessor journal is Acta Endocrinologica.
The journal publishes high-quality original clinical and translational research papers and reviews in paediatric and adult endocrinology, as well as clinical practice guidelines, position statements and debates. Case reports will only be considered if they represent exceptional insights or advances in clinical endocrinology.
Topics covered include, but are not limited to, Adrenal and Steroid, Bone and Mineral Metabolism, Hormones and Cancer, Pituitary and Hypothalamus, Thyroid and Reproduction. In the field of Diabetes, Obesity and Metabolism we welcome manuscripts addressing endocrine mechanisms of disease and its complications, management of obesity/diabetes in the context of other endocrine conditions, or aspects of complex disease management. Reports may encompass natural history studies, mechanistic studies, or clinical trials.
Equal consideration is given to all manuscripts in English from any country.